China's EpimAb Advances Bispecific Antibody To Rival Janssen Candidate

 
• By Sten Stovall
  
Success
EpimAb is using its platform to develop a pipeline of bispecific antibodies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business